序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
181 PREBIOTIC COMPOSITIONS AND METHODS OF USE EP13775460.2 2013-03-13 EP2836218A1 2015-02-18 NEWBURG, David, S.; YU, Zhuoteng
Provided herein are prebiotic compositions comprising a combination of oligosaccharides such as sialyated oligosaccharides and fusocylated oligosaccharides, and uses thereof in stimulating the proliferation of beneficial intestinal micro biota, for example, of bifidobacteria, and/or in decreasing the abundance of enteric pathogens. The prebiotic compositions can further contain a probiotic, which can be a population of bifidobacteria, lactobacilli, Bacteriodes fragilis, Bacteriodes thetaiotaomicron, Enterococcus faecalis (pro biotic strains thereof), Staphylococcus epidermides, Enterobacter aerogenes, Enterobacter cloacae, or related bacteria having similar functions.
182 PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION EP06799537.3 2006-10-06 EP1940246B1 2010-08-11 SCHMITT, Joachim; STAHL, Bernd; KNOL, Jan
The present invention relates to methods for feeding and to compositions to be adminis
183 COMPOSITION FOR PREVENTING OR TREATING ARTRITIS COMPRISING LACTIC ACID BACTERIA AND COLLANGEN AS ACTIVE INGREDIENTS EP06798857 2006-09-22 EP1945234A4 2010-04-21 IM SIN HYEOG; SO JAE SEON; YI HWA JOONG
The present invention relates to a composition for preventing or treating arthritis, which comprises a lactic acid bacterium and collagen as major active ingredients. The present composition shows excellent prevention or treatment efficacies on arthritis of animal models. In addition, since the active ingredients used in the composition of this invention have been recognized to be safe to human, the present composition has considerable safety with enhanced immunomodulatory effect in patients with arthritis.
184 METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION EP06799536.5 2006-10-06 EP1940245B1 2009-08-26 SCHMITT, Joachim; STAHL, Bernd; KNOL, Jan
The present invention relates to methods for feeding and to compositions to be adminis
185 METHOD FOR STIMULATING THE INTESTINAL FLORA EP06806443.5 2006-10-20 EP1940250A1 2008-07-09 BOEHM, Günther; STAHL, Bernd; KNOL, Jan
The present invention relates to methods for feeding and to compositions to be adminis
186 METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH EP06799538.1 2006-10-06 EP1940247A2 2008-07-09 SCHMITT, Joachim; BOEHM, Gunther; BEERMANN, Christopher
The present invention relates to methods for feeding and to compositions to be adminis
187 MIXTURE OF AT LEAST 6 SPECIES OF LACTIC ACID BACTERIA AND/OR BIFIDOBACTERIA IN THE MANUFACTURE OF SOURDOUGH EP06724958.1 2006-03-07 EP1858336A1 2007-11-28 DE SIMONE, Claudio; PIROVANO, Franco
A mixture of at least 6 species of lactic acid bacteria and/or Bifidobacteria is disclosed for use in bakery and medical field. The preferred mixture comprises Streptococcus thermophilus, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium breve, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus delbrueckii subsp. bulgaricus. Said mixture is useful for a sourdough, a leavening composition. Baked goods and other food products obtained therefrom are disclosed. These goods have low or no gluten content and are suitable for the integration of the diet of a subject suffering from celiac disease, for decreasing the risk of allergies due to wheat flour albumins and globulins, for the treatment of schizophrenic symptoms, in the preparation of products for enteric diet.
188 Method for stimulating the intestinal flora EP05023029.1 2005-10-21 EP1776877A1 2007-04-25 Boehm, Guenther, Prof. Dr.; Knol, Jan; Stahl, Bernd, Dr.

The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.

189 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it EP05112280.2 2002-12-19 EP1652913A1 2006-05-03 de Simone, Claudio

The use of the said strain is particularly effective in the prevention/treatment of hepatic steatosis (fatty liver) and in nonalcoholic hepatic steatosis.

190 COMBINATION OF PROBIOTICS EP02710896.8 2002-01-17 EP1359816B1 2005-06-15 MÄYRÄ-MÄKINEN, Annika; SUOMALAINEN, Tarja; VAARALA, Outi
The invention relates to a probiotic combination comprising different combinations of lactobacilli, propionic acid bacteria and/or bifidobacteria. The probiotics are preferably combined with a suitable prebiotic to form a synbiotic. The combination of the invention can be consumed as such or combined with a suitable foodstuff or pharmaceutical product, and it is therapeutically useful for example for stimulating the immune system and for general health improvement.
191 Culture de bifidobactéries résistantes à l'acide EP86101202.9 1986-01-30 EP0192986B2 1998-12-09 Sozzi, Tomaso
192 Culture de bifidobactéries résistantes à l'acide EP86101202.9 1986-01-30 EP0192986B1 1989-08-16 Sozzi, Tomaso
193 METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH PCT/NL2006050248 2006-10-06 WO2007046699A3 2007-11-01 SCHMITT JOACHIM; BOEHM GUNTHER; BEERMANN CHRISTOPHER
The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides.
194 COMBINATION OF PROBIOTICS PCT/FI0200035 2002-01-17 WO02060276A9 2002-10-03 MAEYRAE-MAEKINEN ANNIKA; SUOMALAINEN TARJA; VAARALA OUTI
The invention relates to a probiotic combination comprising different combinations of lactobacilli, propionic acid bacteria and/or bifidobacteria. The probiotics are preferably combined with a suitable prebiotic to form a synbiotic. The combination of the invention can be consumed as such or combined with a suitable foodstuff or pharmaceutical product, and it is therapeutically useful for example for stimulating the immune system and for general health improvement.
QQ群二维码
意见反馈